EUA

US FDA Authorizes Pfizer/BioNTech Vaccine for Emergency Use

  • The US Food and Drug Administration granted an emergency use authorization for the  Pfizer vaccine, developed with German partner BioNTech.
  • The vaccine was shown to be 95% effective in preventing the disease in a late-stage trial.
  • Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses.

The US Food and Drug Administration has authorized the first Covid-19 vaccine for emergency use in the United States,...

https://mfame.guru/us-fda-authorizes-pfizer-biontech-vaccine-for-emergency-use/

[Watch] FDA Discusses the Pros & Cons of Emergency Vaccine Authorisation

A health worker injects a person during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, U.S., on Wednesday, Sept. 9, 2020. Drugmakers racing to produce Covid-19 vaccines pledged to avoid shortcuts on science as they face pressure to rush a shot to market. Photographer: Eva Marie Uzcategui/Bloomberg via Getty Images

According to a Science Magazine report, last week an advisory group to the U.S. Food and Drug Administration (FDA)  raised concerns that...

https://mfame.guru/watch-fda-discusses-the-pros-cons-of-emergency-vaccine-authorisation/

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon
By subscribing, you agree with our privacy policy and our terms of service.